Sophie Taillibert
Paris, 75013, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis.
Journal: Neuro-oncology
Published: July 22, 2022
The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns.
Journal: International journal of radiation oncology, biology, physics
Published: August 12, 2021
Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial.
Journal: JAMA oncology
Published: February 03, 2018
Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 13, 2017
Neoplastic Meningitis Due to Lung, Breast, and Melanoma Metastases.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: February 09, 2017
Leptomeningeal metastases: a RANO proposal for response criteria.
Journal: Neuro-oncology
Published: January 01, 2017
Chemotherapy-Related Neurotoxicity.
Journal: Current neurology and neuroscience reports
Published: July 23, 2016
Systemic therapy for recurrent meningioma.
Journal: Expert review of neurotherapeutics
Published: April 29, 2016
Current Management of Adult Diffuse Infiltrative Low Grade Gliomas.
Journal: Current neurology and neuroscience reports
Published: January 12, 2016
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.
Journal: JAMA
Published: December 17, 2015
Last Updated: 09/26/2026